https://www.zonebourse.com/cours/action/MEDIGEN-BIOTECHNOLOGY-COR-15831545/actualite/Medigen-Biotechnology-Corp-depose-une-demande-d-essai-clinique-de-phase-I-II-de-cellules-tueuses-n-46068325/?utm_source=telegram&utm_medium=social&utm_campaign=share